JPMorgan Chase & Co. Analysts Give Evonik Industries (FRA:EVK) a €21.00 Price Target

JPMorgan Chase & Co. set a €21.00 ($24.42) target price on Evonik Industries (FRA:EVK) in a research report report published on Tuesday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

Several other research analysts have also weighed in on the company. Independent Research set a €26.00 ($30.23) price target on Evonik Industries and gave the stock a neutral rating in a research report on Thursday, March 5th. Baader Bank set a €29.50 ($34.30) price target on Evonik Industries and gave the stock a buy rating in a research report on Wednesday, March 4th. Barclays set a €28.50 ($33.14) price target on Evonik Industries and gave the stock a buy rating in a research report on Tuesday, March 10th. Warburg Research set a €36.00 ($41.86) price target on Evonik Industries and gave the stock a buy rating in a research report on Wednesday, March 4th. Finally, DZ Bank reaffirmed a buy rating on shares of Evonik Industries in a research report on Monday, March 9th. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and nine have assigned a buy rating to the stock. Evonik Industries presently has a consensus rating of Hold and a consensus target price of €26.95 ($31.34).

FRA EVK opened at €19.18 ($22.30) on Tuesday. The stock’s 50 day moving average price is €22.75 and its two-hundred day moving average price is €24.51. Evonik Industries has a 52 week low of €26.78 ($31.14) and a 52 week high of €32.97 ($38.34).

About Evonik Industries

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.

Featured Story: Understanding debt-to-equity ratio in fundamental analysis

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.